Exact Mass: 498.4284

TG(10:0/8:0/8:0)

C29H54O6 (498.392)

TG(10:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(10:0/8:0/8:0) is made up of one decanoyl(R1), one octanoyl(R2), and one octanoyl(R3).

TG(8:0/8:0/10:0)

C29H54O6 (498.392)

TG(8:0/8:0/10:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/10:0) is made up of one octanoyl(R1), one octanoyl(R2), and one decanoyl(R3).

DG(8:0/19:0/0:0)

C30H58O5 (498.4284)

DG(8:0/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/19:0)

C30H58O5 (498.4284)

DG(8:0/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/i-19:0/0:0)

C30H58O5 (498.4284)

DG(8:0/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/i-19:0)

C30H58O5 (498.4284)

DG(8:0/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/17:0/0:0)

C30H58O5 (498.4284)

DG(10:0/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/17:0)

C30H58O5 (498.4284)

DG(10:0/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/i-17:0/0:0)

C30H58O5 (498.4284)

DG(10:0/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/i-17:0)

C30H58O5 (498.4284)

DG(10:0/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/a-17:0/0:0)

C30H58O5 (498.4284)

DG(10:0/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/a-17:0)

C30H58O5 (498.4284)

DG(10:0/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/15:0/0:0)

C30H58O5 (498.4284)

DG(12:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/15:0)

C30H58O5 (498.4284)

DG(12:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/15:0/0:0)

C30H58O5 (498.4284)

DG(i-12:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/15:0)

C30H58O5 (498.4284)

DG(i-12:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/a-15:0/0:0)

C30H58O5 (498.4284)

DG(i-12:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/a-15:0)

C30H58O5 (498.4284)

DG(i-12:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/i-15:0/0:0)

C30H58O5 (498.4284)

DG(i-12:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/i-15:0)

C30H58O5 (498.4284)

DG(i-12:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/i-15:0/0:0)

C30H58O5 (498.4284)

DG(12:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/i-15:0)

C30H58O5 (498.4284)

DG(12:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/a-15:0/0:0)

C30H58O5 (498.4284)

DG(12:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/a-15:0)

C30H58O5 (498.4284)

DG(12:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/14:0/0:0)

C30H58O5 (498.4284)

DG(13:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/14:0)

C30H58O5 (498.4284)

DG(13:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/14:0/0:0)

C30H58O5 (498.4284)

DG(i-13:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/14:0)

C30H58O5 (498.4284)

DG(i-13:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/i-14:0/0:0)

C30H58O5 (498.4284)

DG(a-13:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/i-14:0)

C30H58O5 (498.4284)

DG(a-13:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/14:0/0:0)

C30H58O5 (498.4284)

DG(a-13:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/14:0)

C30H58O5 (498.4284)

DG(a-13:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/i-14:0/0:0)

C30H58O5 (498.4284)

DG(i-13:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/i-14:0)

C30H58O5 (498.4284)

DG(i-13:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/i-14:0/0:0)

C30H58O5 (498.4284)

DG(13:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/i-14:0)

C30H58O5 (498.4284)

DG(13:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/13:0/0:0)

C30H58O5 (498.4284)

DG(14:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/13:0)

C30H58O5 (498.4284)

DG(14:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/13:0/0:0)

C30H58O5 (498.4284)

DG(i-14:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/13:0)

C30H58O5 (498.4284)

DG(i-14:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/a-13:0/0:0)

C30H58O5 (498.4284)

DG(i-14:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/a-13:0)

C30H58O5 (498.4284)

DG(i-14:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/i-13:0/0:0)

C30H58O5 (498.4284)

DG(i-14:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/i-13:0)

C30H58O5 (498.4284)

DG(i-14:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/i-13:0/0:0)

C30H58O5 (498.4284)

DG(14:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/i-13:0)

C30H58O5 (498.4284)

DG(14:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/a-13:0/0:0)

C30H58O5 (498.4284)

DG(14:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/a-13:0)

C30H58O5 (498.4284)

DG(14:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/12:0/0:0)

C30H58O5 (498.4284)

DG(15:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/12:0)

C30H58O5 (498.4284)

DG(15:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/12:0/0:0)

C30H58O5 (498.4284)

DG(i-15:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/12:0)

C30H58O5 (498.4284)

DG(i-15:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/i-12:0/0:0)

C30H58O5 (498.4284)

DG(a-15:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/i-12:0)

C30H58O5 (498.4284)

DG(a-15:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/12:0/0:0)

C30H58O5 (498.4284)

DG(a-15:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/12:0)

C30H58O5 (498.4284)

DG(a-15:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/i-12:0/0:0)

C30H58O5 (498.4284)

DG(i-15:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/i-12:0)

C30H58O5 (498.4284)

DG(i-15:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/i-12:0/0:0)

C30H58O5 (498.4284)

DG(15:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/i-12:0)

C30H58O5 (498.4284)

DG(15:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(17:0/10:0/0:0)

C30H58O5 (498.4284)

DG(17:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(17:0/0:0/10:0)

C30H58O5 (498.4284)

DG(17:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/10:0/0:0)

C30H58O5 (498.4284)

DG(i-17:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-17:0/0:0/10:0)

C30H58O5 (498.4284)

DG(i-17:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/10:0/0:0)

C30H58O5 (498.4284)

DG(a-17:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-17:0/0:0/10:0)

C30H58O5 (498.4284)

DG(a-17:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(19:0/8:0/0:0)

C30H58O5 (498.4284)

DG(19:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/8:0)

C30H58O5 (498.4284)

DG(19:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/8:0/0:0)

C30H58O5 (498.4284)

DG(i-19:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/8:0)

C30H58O5 (498.4284)

DG(i-19:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Dihydroplakinamine K

C32H54N2O2 (498.4185)

Scorodocarpine A

C32H54N2O2 (498.4185)

.beta.-Amyrin trimethylsilyl ether

C33H58OSi (498.4257)

3beta-acetoxy-11alpha-methoxy-12-ursene

C33H54O3 (498.4073)

19,11:14,15-diepoxy-tetramethylsqualene

C34H58O2 (498.4437)

NSC129990

C33H54O3 (498.4073)

3alpha-acetoxy-24-hydroxy-24-methyl-5alpha-lanosta-9(11),25-diene

C33H54O3 (498.4073)

.alpha.-Amyrin, TMS derivative

C33H58OSi (498.4257)

2,3-Dihydroxypropyl octacosanoate

C31H62O4 (498.4648)

C33H54O3

C33H54O3 (498.4073)

3alpha-acetoxy-25-methoxylanosta-8,23-diene|3??-Acetoxy-25-methoxy-lanosta-8,23-diene

C33H54O3 (498.4073)

(22R)-30a,30b-dihomohopan-30b-ol acetate

C34H58O2 (498.4437)

3beta-acetoxy-22alpha-methoxy-20-taraxastene

C33H54O3 (498.4073)

2-Palmitoyl-1,3-diisovalerin

C29H54O6 (498.392)

plakinamine M

C33H58N2O (498.4549)

19,21-dimethyldotriacont-17,22,24,26,28-pentaenoic acid

C34H58O2 (498.4437)

cycloartane-24-en-1alpha,2alpha,3beta-triol-1,2-acetonide

C33H54O3 (498.4073)

3beta-acetoxycycloart-25-methoxy-23-ene

C33H54O3 (498.4073)

Antibiotic SF 2425

C25H54N8O2 (498.437)

3beta-acetoxy-19alpha-methoxy-20-taraxastene

C33H54O3 (498.4073)

cholest-5-en-3-yl heptanoate

C34H58O2 (498.4437)

1-Dehydroxy-23-deoxojessic acid

C33H54O3 (498.4073)

Glyceryl montanate

C31H62O4 (498.4648)

N-behenoyl-5-hydroxytryptamide

C32H54N2O2 (498.4185)

34:5(w3)

C34H58O2 (498.4437)

34:5(w6)

C34H58O2 (498.4437)

Myristoleyl arachidonate

C34H58O2 (498.4437)

FA 34:5

C34H58O2 (498.4437)

WE 34:5

C34H58O2 (498.4437)

Behenylserotonin

C32H54N2O2 (498.4185)

Olaflur

C27H60F2N2O3 (498.4572)

A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AA - Caries prophylactic agents D020011 - Protective Agents > D002327 - Cariostatic Agents > D005459 - Fluorides C26170 - Protective Agent

14-CARBOXYTETRADECYL 15-HYDROXYPENTADEC&

C30H58O5 (498.4284)

Cholesteryl heptanoate

C34H58O2 (498.4437)

Silane, (1,1-diMethylethyl)diMethyl[[(3β,5E,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl]oxy]-

C33H58OSi (498.4257)

1-O-hexadecyl-2-O-lauroyl-sn-glycerol

C31H62O4 (498.4648)

Glyceryl 1-caprate dicaprylate

C29H54O6 (498.392)

Lanosterol-trimethylsilyl-ether

C33H58OSi (498.4257)

[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] pentadecanoate

C30H58O5 (498.4284)

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] tetradecanoate

C30H58O5 (498.4284)

(3-Carboxy-2-tricosanoyloxypropyl)-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(12-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(19-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(21-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(13-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(9-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(7-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(17-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(10-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(5-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(15-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(6-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(20-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(16-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(8-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(4-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(3-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(11-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(14-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-Carboxy-2-(18-methyldocosanoyloxy)propyl]-trimethylazanium

C30H60NO4+ (498.4522)

[3-carboxy-2-[(E)-14-hydroxydocos-16-enoyl]oxypropyl]-trimethylazanium

C29H56NO5+ (498.4158)

(2R)-23-oxotetracosan-2-yl alpha-L-ascaroside

C30H58O5 (498.4284)

A hydroxy ketone ascaroside obtained by obtained by formal condensation of the 23-hydroxy group of (23R)-23-hydroxytetracosan-2-one with ascarylopyranose (the alpha-anomer). It is a metabolite of the nematode Caenorhabditis elegans.

1,2-Dicaproyl-3-myristoylglycerol

C29H54O6 (498.392)

(1-Hexadecoxy-3-hydroxypropan-2-yl) dodecanoate

C31H62O4 (498.4648)

(1-Decoxy-3-hydroxypropan-2-yl) octadecanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-tridecoxypropan-2-yl) pentadecanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-tridecanoyloxypropan-2-yl) tetradecanoate

C30H58O5 (498.4284)

NAOrn 13:0/10:0

C28H54N2O5 (498.4033)

NAOrn 11:0/12:0

C28H54N2O5 (498.4033)

NAOrn 10:0/13:0

C28H54N2O5 (498.4033)

NAOrn 12:0/11:0

C28H54N2O5 (498.4033)

(1-Hydroxy-3-nonadecoxypropan-2-yl) nonanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-pentacosoxypropan-2-yl) propanoate

C31H62O4 (498.4648)

(1-Hexacosoxy-3-hydroxypropan-2-yl) acetate

C31H62O4 (498.4648)

(1-Hydroxy-3-octoxypropan-2-yl) icosanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-nonoxypropan-2-yl) nonadecanoate

C31H62O4 (498.4648)

(1-Docosoxy-3-hydroxypropan-2-yl) hexanoate

C31H62O4 (498.4648)

(1-Henicosoxy-3-hydroxypropan-2-yl) heptanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-tricosoxypropan-2-yl) pentanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-icosoxypropan-2-yl) octanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-tetracosoxypropan-2-yl) butanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-tetradecoxypropan-2-yl) tetradecanoate

C31H62O4 (498.4648)

(1-Dodecoxy-3-hydroxypropan-2-yl) hexadecanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-octadecoxypropan-2-yl) decanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-undecoxypropan-2-yl) heptadecanoate

C31H62O4 (498.4648)

(1-Hydroxy-3-pentadecoxypropan-2-yl) tridecanoate

C31H62O4 (498.4648)

(1-Heptadecoxy-3-hydroxypropan-2-yl) undecanoate

C31H62O4 (498.4648)

(2-Nonanoyloxy-3-octanoyloxypropyl) nonanoate

C29H54O6 (498.392)

(1-Hydroxy-3-nonanoyloxypropan-2-yl) octadecanoate

C30H58O5 (498.4284)

(1-Hydroxy-3-undecanoyloxypropan-2-yl) hexadecanoate

C30H58O5 (498.4284)

(1-Decanoyloxy-3-hydroxypropan-2-yl) heptadecanoate

C30H58O5 (498.4284)

(1-Dodecanoyloxy-3-hydroxypropan-2-yl) pentadecanoate

C30H58O5 (498.4284)

(1-Acetyloxy-3-hydroxypropan-2-yl) pentacosanoate

C30H58O5 (498.4284)

(1-Hydroxy-3-octanoyloxypropan-2-yl) nonadecanoate

C30H58O5 (498.4284)

(1-Butanoyloxy-3-hydroxypropan-2-yl) tricosanoate

C30H58O5 (498.4284)

(1-Hydroxy-3-propanoyloxypropan-2-yl) tetracosanoate

C30H58O5 (498.4284)

(1-Hydroxy-3-pentanoyloxypropan-2-yl) docosanoate

C30H58O5 (498.4284)

(1-Hexanoyloxy-3-hydroxypropan-2-yl) henicosanoate

C30H58O5 (498.4284)

(1-Heptanoyloxy-3-hydroxypropan-2-yl) icosanoate

C30H58O5 (498.4284)

[(2S)-3-hydroxy-2-undecanoyloxypropyl] hexadecanoate

C30H58O5 (498.4284)

[1-carboxy-3-[2-hydroxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C28H52NO6+ (498.3794)

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] hexadecanoate

C30H58O5 (498.4284)

[1-carboxy-3-[2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C28H52NO6+ (498.3794)

[(2S)-2,3-di(octanoyloxy)propyl] decanoate

C29H54O6 (498.392)

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] nonadecanoate

C30H58O5 (498.4284)

[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] 13-methyltetradecanoate

C30H58O5 (498.4284)

[(2R)-2-hydroxy-3-octanoyloxypropyl] nonadecanoate

C30H58O5 (498.4284)

(19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoic acid

C34H58O2 (498.4437)

A very long-chain omega-3 fatty acid that is tetratriacontapentaenoic acid having five double bonds located at positions 19, 22, 25 ,28 and 31 (the 19Z,22Z,25Z,28Z,31Z-isomer).

(16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoic acid

C34H58O2 (498.4437)

A very long-chain omega-6 fatty acid that is tetratriacontapentaenoic acid having five double bonds located at positions 16, 19, 22, 25 and 28 (the 16Z,19Z,22Z,25Z,28Z-isomer).

Hydroxytritriacontahexaenoic acid

C33H54O3 (498.4073)

Tetratriacontapentaenoic acid

C34H58O2 (498.4437)

NA-Trp 20:0

C31H50N2O3 (498.3821)

DG 10:0_17:0

C30H58O5 (498.4284)

DG 11:0_16:0

C30H58O5 (498.4284)

DG 12:0_15:0

C30H58O5 (498.4284)

DG 13:0_14:0

C30H58O5 (498.4284)

DG 27:0

C30H58O5 (498.4284)

DG O-14:0_14:0

C31H62O4 (498.4648)

DG O-16:0_12:0

C31H62O4 (498.4648)

DG O-18:0_10:0

C31H62O4 (498.4648)

DG O-28:0

C31H62O4 (498.4648)

MG 28:0

C31H62O4 (498.4648)

TG 26:0

C29H54O6 (498.392)

TG 8:0_8:0_10:0

C29H54O6 (498.392)

TG 8:0/8:0/10:0

C29H54O6 (498.392)

1-(5-hydroxy-5,6-dimethylhept-6-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O3 (498.4073)

[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]trimethylsilane

C33H58OSi (498.4257)

(1r,3ar,5ar,6r,7r,9ar,9br,11ar)-1-[(2r)-1-[(2r,3r)-3-isopropylpyrrolidin-2-yl]propan-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C32H54N2O2 (498.4185)

(1s,6r,8r,11r,12s,15s,16r,19s,21s)-19-methoxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C33H54O3 (498.4073)

(1s,6r,8r,11r,12s,15s,16r,19r,21r)-19-methoxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C33H54O3 (498.4073)

(1s,3as,5as,6s,7s,9as,9bs,11as)-1-[(2s)-1-[(2r,3r)-3-isopropylpyrrolidin-2-yl]propan-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C32H54N2O2 (498.4185)

3β-acetoxy-25-methoxy-lanosta-8,23-diene

C33H54O3 (498.4073)

{"Ingredient_id": "HBIN008145","Ingredient_name": "3\u03b2-acetoxy-25-methoxy-lanosta-8,23-diene","Alias": "NA","Ingredient_formula": "C33H54O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "252","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,2e,6e,9e)-3,7,11,11-tetramethyl-8-oxocycloundeca-2,6,9-trien-1-yl (9z)-octadec-9-enoate

C33H54O3 (498.4073)

(2s,3s)-2-methyl-3-{2-[(2s,3s)-3-methyl-3-[(3r,7r)-3,7,8-trimethyl-4-methylidenenon-8-en-1-yl]oxiran-2-yl]ethyl}-2-[(3r,7s)-3,7,8-trimethyl-4-methylidenenon-8-en-1-yl]oxirane

C34H58O2 (498.4437)

(2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)methyl octadeca-9,12-dienoate

C33H54O3 (498.4073)

{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}trimethylsilane

C33H58OSi (498.4257)

(4r)-4-[(3r,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]pentyl acetate

C34H58O2 (498.4437)

3,7,11,11-tetramethyl-8-oxocycloundeca-2,6,9-trien-1-yl octadec-9-enoate

C33H54O3 (498.4073)

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-19-methoxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C33H54O3 (498.4073)

n-[2-(5-hydroxy-1h-indol-3-yl)ethyl]docosanimidic acid

C32H54N2O2 (498.4185)

14-methoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl acetate

C33H54O3 (498.4073)

19-methoxy-1,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C33H54O3 (498.4073)

2-methyl-3-{2-[3-methyl-3-(3,7,8-trimethyl-4-methylidenenon-8-en-1-yl)oxiran-2-yl]ethyl}-2-(3,7,8-trimethyl-4-methylidenenon-8-en-1-yl)oxirane

C34H58O2 (498.4437)

(2r)-2,3-dihydroxypropyl octacosanoate

C31H62O4 (498.4648)

(3r,4ar,6ar,6bs,8ar,11r,12s,12ar,14r,14ar,14bs)-14-methoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl acetate

C33H54O3 (498.4073)

(1r,3as,3bs,5ar,7r,9as,11ar)-1-[(2r,5r)-5-hydroxy-5,6-dimethylhept-6-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O3 (498.4073)

{[(3r,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl]oxy}trimethylsilane

C33H58OSi (498.4257)

1-[1-(3-isopropylpyrrolidin-2-yl)propan-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C32H54N2O2 (498.4185)

{3,6,7b-trimethyl-4-oxo-1h,2h,5h,7h-cyclobuta[e]inden-6-yl}methyl octadecanoate

C33H54O3 (498.4073)

4-{5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl}pentyl acetate

C34H58O2 (498.4437)

[(6s,7bs)-3,6,7b-trimethyl-4-oxo-1h,2h,5h,7h-cyclobuta[e]inden-6-yl]methyl octadecanoate

C33H54O3 (498.4073)

(1r,3ar,5ar,6r,7r,9ar,9br,11ar)-1-[(2r)-1-(3-isopropylpyrrolidin-2-yl)propan-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C32H54N2O2 (498.4185)

[(4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl)oxy]trimethylsilane

C33H58OSi (498.4257)